Grant
EP PerMed call: EIS support for Estonian companies in personalised medicine projects
EIS funds Estonian companies taking part in international applied research and product development projects on cell and gene therapies under the European Partnership for Personalised Medicine call. EIS supports the participating companies with a total of 500,000 euros, funded by the state budget and co-funded by Horizon Europe.
See your fitKey facts
- Organiser
- Ettevõtluse ja Innovatsiooni Sihtasutus (EIS)
- Deadline
- January 20, 2027
- Opens
- November 4, 2026
- Amount
- Grant
- Open to
- Estonia
- Sectors
- Biotech, Healthtech
4 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about EP PerMed call: EIS support for Estonian companies in personalised medicine projects
Who can apply to EP PerMed call: EIS support for Estonian companies in personalised medicine projects?
Eligible locations: Estonia. The company must be incorporated in Estonia. Only startups in these sectors qualify: Biotech and Healthtech. Other requirements: Must join an international consortium of universities, research bodies, hospitals and companies; Consortium must include patient organisations and patient or citizen representing non-profits; Projects on cell and gene therapies, incl. mRNA and other novel biological therapies.
When is the EP PerMed call: EIS support for Estonian companies in personalised medicine projects deadline?
The EP PerMed call: EIS support for Estonian companies in personalised medicine projects deadline is January 20, 2027. Applications open on November 4, 2026.
Other programs in this category
Verified on November 3, 2026 against the official page.